Deciphera Pharmaceuticals Competitors and Similar CompaniesClear all
Deciphera Pharmaceuticals's competitors and similar companies include Exelixis, Celldex Therapeutics, Bristol Myers Squibb, Blueprint Medicines, Arog Pharmaceuticals and Allakos.
 Deciphera Pharmaceuticals Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer. |  Celldex Therapeutics Celldex Therapeutics (formerly Avant Immunotherapeutics) is a biopharmaceutical company that specializes in monoclonal and bispecific antibodies development. |  Bristol Myers Squibb Bristol-Myers Squibb (BMS) is a company engaged in the discovery, development, licensing, manufacturing, marketing, and distribution of biopharmaceutical products. |  Blueprint Medicines Blueprint Medicines is a biopharmaceutical company engaged in developing therapies for allergy, inflammation, and oncology/hematology. |  Arog Pharmaceuticals Arog Pharmaceuticals is a biopharmaceutical company dedicated to improving the lives of cancer patients by developing crenolanib in indications with high unmet need. |  Allakos Allakos is a biotechnology company that develops therapeutics targeting allergic, inflammatory, and proliferative diseases. | ||
Founding Date | Founding Date 2003 | Founding Date 1994 | Founding Date 1983 | Founding Date 1887 | Founding Date 2011 | Founding Date 2010 | Founding Date 2012 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public | Type Private | Type Subsidiary |
Tags | |||||||
Locations | Locations Waltham, US HQ Lawrence, US | Locations Alameda, US HQ | Locations Hampton, US HQ Fall River, US Needham, US New Haven, US | Locations Princeton, US HQ Mulgrave, AU Pinewood, AU Wien, AT Braine L'alleud, BE Bruxelles, BE São Paulo, BR see more | Locations Cambridge, US HQ Amsterdam, NL Lugano, CH Zug, CH | Locations Plano, US HQ | Locations San Carlos, US HQ |
Employees | Employees 35037% increase | Employees 1,14712% decrease | Employees 1608% increase | Employees 34,100 | Employees 6552% increase | Employees 913% increase | Employees 6153% decrease |
Valuation ($) | Valuation ($) 2.2 b | Valuation ($) 8.2 b | Valuation ($) 1.9 b | Valuation ($) 97.8 b | Valuation ($) 5.3 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||||
Revenue (est.) | Revenue (est.) $163.4m (FY, 2023) | Revenue (est.) $2.3b (FY, 2025) | Revenue (est.) $1.5m (FY, 2025) | Revenue (est.) $48.2b (FY, 2025) | Revenue (est.) $508.8m (FY, 2024) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods $3.7m (FY, 2023) | Cost of goods $83.7m (FY, 2025) | Cost of goods $200k (FY, 2025) | Cost of goods $13.9b (FY, 2025) | Cost of goods $20.2m (FY, 2024) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $159.6m (FY, 2023) | Gross profit $2.2b (FY, 2025) | Gross profit $1.3m (FY, 2025) | Gross profit $34.3b (FY, 2025) | Gross profit $488.7m (FY, 2024) | Gross profit N/A | Gross profit N/A |
Net income | Net income ($194.9m) (FY, 2023) | Net income $782.6m (FY, 2025) | Net income ($258.8m) (FY, 2025) | Net income $7.1b (FY, 2025) | Net income ($67.1m) (FY, 2024) | Net income ($11.6m) (FY, 2017) | Net income ($115.8m) (FY, 2024) |
Funding | |||||||
Total funding raised | Total funding raised $ 714m | Total funding raised N/A | Total funding raised $ 2m | Total funding raised $ 15.5m | Total funding raised $ 1.7b | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Exelixis
HQ
Alameda, US
Employees
1,147↓ 12% decrease
Exelixis is an oncology company that develops cancer treatments.
View companyCelldex Therapeutics
HQ
Hampton, US
Employees
160↑ 8% increase
Celldex Therapeutics (formerly Avant Immunotherapeutics) is a biopharmaceutical company that specializes in monoclonal and bispecific antibodies development.
View companyBristol Myers Squibb
HQ
Princeton, US
Employees
34,100
Bristol-Myers Squibb (BMS) is a company engaged in the discovery, development, licensing, manufacturing, marketing, and distribution of biopharmaceutical products.
View companyBlueprint Medicines
HQ
Cambridge, US
Employees
655↑ 2% increase
Blueprint Medicines is a biopharmaceutical company engaged in developing therapies for allergy, inflammation, and oncology/hematology.
View company